Ren, H., Bakas, N. A., Vamos, M., Chaikuad, A., Limpert, A. S., Wimer, C. D., . . . Cosford, N. D. P. (2020). Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer. J Med Chem.
Citação norma ChicagoRen, Huiyu, et al. "Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor That Synergizes With the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer." J Med Chem 2020.
MLA引文Ren, Huiyu, et al. "Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor That Synergizes With the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer." J Med Chem 2020.